[go: up one dir, main page]

YU140391A - 6-supstituisani-heksahidrobenz (cd)-indoli - Google Patents

6-supstituisani-heksahidrobenz (cd)-indoli

Info

Publication number
YU140391A
YU140391A YU140391A YU140391A YU140391A YU 140391 A YU140391 A YU 140391A YU 140391 A YU140391 A YU 140391A YU 140391 A YU140391 A YU 140391A YU 140391 A YU140391 A YU 140391A
Authority
YU
Yugoslavia
Prior art keywords
substituted
hexachydrobenze
indoles
pharmaceutically acceptable
acceptable salts
Prior art date
Application number
YU140391A
Other languages
English (en)
Inventor
M.E. Flaugh
M.J. Martinelli
Jm. Schaus
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of YU140391A publication Critical patent/YU140391A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Addiction (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

6-SUPSTITUISANI-HEKSAHIDROBENZ (CD)-INDOLI, opisano je jedinjenje formule u kojoj R1, R2, R3, R7 i A imaju značenja definisana u opisu i pridodatim zahtevima, njegove farmaceutski prihvatljive soli, postupci za njihovo dobijanje kao i formulacije koje sadrže ta jedinjenja, odnosno njegove farmaceutski prihvatljive soli, jedinjenja koja su korisna za tretiranje različitih poremećaja koji su u vezi sa serotonin funkcijom u organizmu.
YU140391A 1990-08-15 1991-08-14 6-supstituisani-heksahidrobenz (cd)-indoli YU140391A (sh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56798790A 1990-08-15 1990-08-15
US07/725,177 US5229410A (en) 1990-08-15 1991-07-03 6-substituted-hexahydrobenz[cd]indoles

Publications (1)

Publication Number Publication Date
YU140391A true YU140391A (sh) 1994-06-10

Family

ID=27074631

Family Applications (1)

Application Number Title Priority Date Filing Date
YU140391A YU140391A (sh) 1990-08-15 1991-08-14 6-supstituisani-heksahidrobenz (cd)-indoli

Country Status (17)

Country Link
US (1) US5229410A (sh)
EP (1) EP0471569A1 (sh)
JP (1) JPH04230664A (sh)
KR (1) KR920004346A (sh)
CN (1) CN1058962A (sh)
AU (1) AU648331B2 (sh)
BR (1) BR9103479A (sh)
CS (1) CS249591A3 (sh)
FI (1) FI913834A (sh)
HU (1) HUT59095A (sh)
IE (1) IE912879A1 (sh)
IL (1) IL99149A0 (sh)
MX (1) MX9100644A (sh)
NO (1) NO176019C (sh)
NZ (1) NZ239334A (sh)
PT (1) PT98639A (sh)
YU (1) YU140391A (sh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204340A (en) * 1989-04-11 1993-04-20 Eli Lilly And Company Tetrahydrobenz(c,d)indole serotonin agonists
ATE149480T1 (de) * 1990-08-15 1997-03-15 Lilly Co Eli Ring-substituierte 2-amino-1,2,3,4-tetra- hydronaphthaline, 3-aminochromane und 3- aminothiochromane
US5654324A (en) * 1991-03-28 1997-08-05 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz[cd]indoles
US5364856A (en) * 1991-03-28 1994-11-15 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD]indoles
US5347013A (en) * 1991-03-28 1994-09-13 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles
US5292766A (en) * 1992-03-25 1994-03-08 Eli Lilly And Company Method for improving primary memory and/or learning
US5385928A (en) * 1994-05-18 1995-01-31 Eli Lilly And Company Tetrahydrobenz [CD] indazoles, compositions and use
AU7112198A (en) 1997-04-15 1998-11-11 Massachusetts Institute Of Technology Synthesis and application of vapor grafted porous materials
KR20050043568A (ko) * 2003-11-06 2005-05-11 김상현 두족류 연체동물 포획용 분할형 인공패각

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE517732C (de) * 1927-10-27 1931-02-09 Then Rudolf Faerbekufe mit einem drehbaren, trommelartigen Rahmen fuer die auf aus-wechselbaren Faerbestoecken aufgehaengten Waren, insbesondere Struempfe
BE542760A (sh) * 1954-11-12
US3194811A (en) * 1963-09-05 1965-07-13 Merck & Co Inc Aroyl-benzindolyl acids
BE755270A (fr) * 1969-08-27 1971-02-25 Sandoz Sa Nouveaux derives du benzo(cd)indole, leur preparation et medicaments contenant ces derives
FI206974A (sh) * 1973-07-16 1975-01-17 Sandoz Ag
US4110339A (en) * 1977-11-25 1978-08-29 Eli Lilly And Company 4-(Di-n-propyl)amino-1,3,4,5-tetrahydrobenz[cd]indole
FR2522658A1 (fr) * 1982-03-05 1983-09-09 Roussel Uclaf Application a titre de medicaments de derives du trans 4-amino benz (c,d) indol-5-ol ainsi que de leurs sels, compositions les renfermant, nouveaux derives et leur procede de preparation
DE3346573A1 (de) * 1983-12-23 1985-07-04 Troponwerke GmbH & Co KG, 5000 Köln 1,3,4,5-tetrahydrobenz(c,d)indole, ein verfahren zu ihrer herstellung und ihre verwendung
US4983622A (en) * 1984-02-06 1991-01-08 Eli Lilly And Company 6-substituted-4-dialkylaminotetrahydrobenz(c,d)indoles
IL74222A (en) * 1984-02-06 1988-07-31 Lilly Co Eli 6-substituted-4-dialkylamino tetrahydrobenz(c,d)indoles,their preparation and pharmaceutical compositions comprising them
US4576959A (en) * 1984-02-06 1986-03-18 Eli Lilly And Company 6-Substituted-4-dialkylaminotetrahydrobenz[c,d]indoles
CA1266482A1 (en) * 1984-05-24 1990-03-06 Carl Kaiser 6-oxygenated-1,3,4,5-tetrahydrobenz(cd)indol-4-amines
DE3525564A1 (de) * 1985-07-15 1987-02-05 Schering Ag Tricyclische verbindungen mit indolstruktur, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
US4745126A (en) * 1987-03-12 1988-05-17 Eli Lilly And Company Method of treating anxiety with tetrahydrobenz[c,d]indole-6-carboxamides
DE3718892A1 (de) * 1987-06-05 1988-12-22 Bayer Ag Polyhydrobenz(c,d)indol-sulfonamide
US5039820A (en) * 1990-02-26 1991-08-13 Eli Lilly And Company 4-amino-6-iodo-hexahydrobenz(cd)indoles
IL97308A (en) * 1990-02-26 1996-10-31 Lilly Co Eli Xahydrobenz [DC] Induced indoles in position 6, their preparation process and pharmaceutical preparations containing them
US5096908A (en) * 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion
US5229409A (en) * 1990-08-15 1993-07-20 Eli Lilly And Company 6-substituted-tetrahydrobenz[cd]indoles
ZA917355B (en) * 1990-09-17 1992-08-26 Agouron Pharma Antiproliferative substituted naphthalene compounds

Also Published As

Publication number Publication date
FI913834A (fi) 1992-02-16
NO913158D0 (no) 1991-08-13
CN1058962A (zh) 1992-02-26
NO176019C (no) 1995-01-18
HUT59095A (en) 1992-04-28
JPH04230664A (ja) 1992-08-19
HU912707D0 (en) 1992-01-28
IE912879A1 (en) 1992-02-26
AU8240791A (en) 1992-02-20
BR9103479A (pt) 1992-05-12
CS249591A3 (en) 1992-03-18
MX9100644A (es) 1992-04-01
US5229410A (en) 1993-07-20
IL99149A0 (en) 1992-07-15
KR920004346A (ko) 1992-03-27
PT98639A (pt) 1992-06-30
NO176019B (no) 1994-10-10
NZ239334A (en) 1993-05-26
EP0471569A1 (en) 1992-02-19
FI913834A0 (fi) 1991-08-13
AU648331B2 (en) 1994-04-21
NO913158L (no) 1992-02-17

Similar Documents

Publication Publication Date Title
MY107157A (en) Quinuclidine derivatives.
TW369526B (en) Diazabicyclic neurokinin antagonists
HUT61543A (en) Process for producing serotonin antagonist indole derivatives and pharmaceutical compositions comprising same as active ingredient
MY108885A (en) Heterocyclic-cyclic amine derivatives.
YU56492A (sh) Derivati hinuklidina
ATE8874T1 (de) Therapeutisch nuetzliche 1-alkyl-2-amino-tetralin- derivate.
ES8801617A1 (es) Un procedimiento para preparar derivados de arilciclobutilalquilamina
DK0598770T3 (da) Pyrazinderivater samt fremstilling og anvendelse deraf
YU140391A (sh) 6-supstituisani-heksahidrobenz (cd)-indoli
DK152090D0 (da) Piperidylsubstituerede indolderivater
TW429255B (en) Pyrazine compounds having treatment of central nervous system diseases and disorders
PL295932A1 (en) Method of obtaining novel bezazepine compounds
YU140491A (sh) 6-supstituisani-tetrahidrobenz(c,d) indoli
FR2687154B1 (fr) Nouveau derive de l'isoindolinone, sa preparation et les compositions pharmaceutiques qui le contiennent.
FR2630110B1 (fr) Nouveaux derives heteroarotinoides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ES2111086T3 (es) Compuestos triciclicos anfoteros como agentes antihistaminicos y antialergicos.
JPS56103183A (en) Pyridazine derivative and its application to medicine
NZ221004A (en) 2,6-piperazinediones and pharamceutical compositions
EP0461264A4 (en) Ethynylphenyl derivative, production thereof, and remedy for diseases of circulatory organs containing the same as active ingredient
EP0668276A4 (en) 2-ALCOXY-5,6,7,8-TETRAHYDROQUINOXALINE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF.
FR2676448B1 (fr) Nouveaux derives amidiques de 1-amino octahydropyrido [2,1-c] [1,4] oxazine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
JPS6419019A (en) Antiamnestic agent
DK0423870T3 (da) Dibenzodioxazecin- dibenzodioxaazacycloundecinderivater